Medicare to cover Merck drug to treat nausea

	Tweet

Medicare will pay for Merck & Co. Inc.’s drug, Emend, when used with two other drugs to treat nausea and vomiting in cancer patients receiving certain chemotherapy, U.S. officials said on Tuesday.

Emend, also known as aprepitant, will be covered when added to treatments given before patients receive highly emetogenic chemotherapy, which can cause severe symptoms, said Medicare, the national health program for the elderly and disabled.

RELATED STORIES:
New vaccine helps guard against cervical cancer   Obesity Predicts Childhood Leukemia Relapse and Survival   Light at Night Might Be a Cancer Risk   Pomegranate extract blocks skin tumors in mice   Can a vegetable cure cancer?   Diet counseling benefits colorectal cancer patients   Sunshine may ward off lymphoma   Blood test accurately detects early ovarian cancer   Cancer-stricken US Supreme Court chief fails to attend hearing   Acupuncture does not reduce radiotherapy-induced nausea, but patients believe it does   Studies Review New Drug and Indications for Heated Chemotherapy   Data support colorectal screening every 5 years

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]